Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Taysha Gene Therapies, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Sold 33,000 shares
@ $2.33, valued at
$76.9k
|
|
| 08/16/2023 |
4
| Manning Paul B (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 16,466,667 shares
@ $0.9, valued at
$14.8M
|
|
| 08/16/2023 |
4
| Stalfort John A III (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 388,889 shares
@ $0.9, valued at
$350k
Bought 388,889 shares
@ $0.9, valued at
$350k
Gifted 50,000 shares
@ $0 |
|
| 08/16/2023 |
4
| Nolan Sean P. (CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 444,444 shares
@ $0.9, valued at
$400k
|
|
| 08/16/2023 |
4
| Donenberg Phillip B. (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 111,111 shares
@ $0.9, valued at
$100k
|
|
| 07/14/2023 |
4
| Session R.A. II (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Sold 80,528 shares
@ $0.7082, valued at
$57k
Sold 5,344 shares
@ $0.7, valued at
$3.7k
|
|
| 05/18/2023 |
4
| Nagendran Sukumar (President and Head of R&D) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 5,000 shares
@ $0.68, valued at
$3.4k
|
|
| 03/08/2023 |
4
| Session R.A. II (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Acquired 251,296 shares
@ $0
Disposed/sold 199,500 options to buy
@ $1.95, valued at
$389k
|
|
| 02/06/2023 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 18,691 shares
@ $0
Granted 37,384 options to buy
@ $1.18, valued at
$44.1k
Granted 149,900 options to buy
@ $1.18, valued at
$176.9k
|
|
| 01/04/2023 |
4
| Nolan Sean P. (CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 1,106,131 options to buy
@ $2.26, valued at
$2.5M
|
|
| 01/04/2023 |
4
| Nagendran Sukumar (President and Head of R&D) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 790,093 options to buy
@ $2.26, valued at
$1.8M
|
|
| 08/24/2022 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Sold 3,325 shares
@ $3.47, valued at
$11.5k
|
|
| 08/22/2022 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Sold 7,476 shares
@ $3.87, valued at
$28.9k
Sold 11,482 shares
@ $3.75, valued at
$43.1k
Sold 9,717 shares
@ $3.5, valued at
$34k
|
|
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Reape Kathleen (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 15,500 options to buy
@ $2.81, valued at
$43.6k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.52, valued at
$260.8k
|
|
| 04/08/2022 |
4
| PRASAD SUYASH (CMO and Head of R&D) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 40,325 options to buy
@ $6.52, valued at
$262.9k
|
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2021 |
4
| Manning Paul B (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 2,202 shares
@ $13.19, valued at
$29k
|
|
| 11/24/2021 |
4
| Manning Paul B (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 20,000 shares
@ $12.54, valued at
$250.8k
|
|
| 08/20/2021 |
4
| Alam Kamran (CFO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Sold 11,193 shares
@ $17.35, valued at
$194.2k
Sold 9,354 shares
@ $16.43, valued at
$153.7k
Sold 613 shares
@ $17.11, valued at
$10.5k
Sold 9,746 shares
@ $16.7, valued at
$162.8k
Sold 2,094 shares
@ $17.14, valued at
$35.9k
|
|
| 06/21/2021 |
4
| Donenberg Phillip B. (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 15,500 options to buy
@ $25.04, valued at
$388.1k
|
|
| 06/21/2021 |
4
| Nagendran Sukumar (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 15,500 options to buy
@ $25.04, valued at
$388.1k
|
|
| 06/21/2021 |
4
| Nolan Sean P. (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 15,500 options to buy
@ $25.04, valued at
$388.1k
|
|
| 06/21/2021 |
4
| Reape Kathleen (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 15,500 options to buy
@ $25.04, valued at
$388.1k
|
|
|
|
|